Abiopharma

Director Wampler Kira Scherer 🟡 adjusted position in 2.0K shares (3 derivative) of Doximity, Inc. (DOCS) at $44.65 Transaction Date: Jan 02, 2026 | Filing ID: 000003

(99% Neutral) Flora Growth Corp. (FLGC) Announces New Board Appointment

(99% Neutral) Estrella Immunopharma, Inc. (ESLA) Announces Business Combination

Stoke Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference

LILLY ENDOWMENT INC 🔴 sold 1.4K shares of ELI LILLY & Co (LLY) at $1,085.01 ($1.5M) Transaction Date: Jan 05, 2026 | Filing ID: 000001

Kiener Peter A 🟢 acquired 24.4K shares (1 derivative) of Cue Biopharma, Inc. (CUE) at $0.34 Transaction Date: Jan 02, 2026 | Filing ID: 004359

Broadfoot Jill Marie 🟢 acquired 24.4K shares (1 derivative) of Cue Biopharma, Inc. (CUE) at $0.34 Transaction Date: Jan 02, 2026 | Filing ID: 004358

Garzone Pamela 🟢 acquired 24.4K shares (1 derivative) of Cue Biopharma, Inc. (CUE) at $0.34 Transaction Date: Jan 02, 2026 | Filing ID: 004356

Morich Frank 🟢 acquired 24.4K shares (1 derivative) of Cue Biopharma, Inc. (CUE) at $0.34 Transaction Date: Jan 02, 2026 | Filing ID: 004357

Verheyen Patrick 🟢 acquired 24.4K shares (1 derivative) of Cue Biopharma, Inc. (CUE) at $0.34 Transaction Date: Jan 02, 2026 | Filing ID: 004355

📋 Grewal Harpreet (Director) plans to sell 186 shares of Penumbra Inc (at $312.64 each, total $58K) Filed: Jan 06, 2026 | ID: 000147

New Form DEF 14A - Theriva Biologics, Inc. Filed: 2026-01-05 AccNo: 0001104659-26-000633 Size: 435 KB

AngioDynamics Inc (ANGO) Files Form 10-Q

Transactions of Managers and Closely Associated Persons

Transactions of Managers and Closely Associated Persons